Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus
about
Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasoundEvaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.Helper-dependent adenoviral vectors for liver-directed gene therapy.Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola VaccineA Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola InfectionDifferential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.Innate immunity to adenovirus.Advances and future challenges in adenoviral vector pharmacology and targeting.The evolution of adenoviral vectors through genetic and chemical surface modifications.Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity.Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice.PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice.Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy.Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors.
P2860
Q30446996-A5F0CBEE-7228-4F6C-B033-A11A13229215Q33742719-1AAA35BB-5220-45FA-9FE0-C713C7EF2962Q34982825-4A2F1031-1DE7-44B4-AB0E-B634BEC7CC0DQ35917496-10D3C414-8BFF-4935-BA18-8D52C48FAA49Q35917501-54BBADE3-6452-43FC-AE68-0F9A81CFE2C6Q36740271-C192B95F-4A89-4D39-AE06-0101FC2F0D96Q37718852-A5A61C4C-61ED-4E8C-9131-7B300D92572EQ37859842-C3FD24E7-AEBA-40FF-80B0-EF014BFD4657Q38189250-0EDE8C45-2405-4999-B16B-21B82F9B5E75Q38684383-2303F53B-4B3D-49C3-BD64-C6AC1DD5525AQ39358889-B72FB2FC-9FE2-4ECC-B724-ADA5CED1EDE3Q39788723-48A7B788-DA24-43B3-A91E-75D182D50F8DQ42281690-737D6464-335B-4FF9-B8EA-FA740AFFACD8Q50977875-BEDDBFD9-F8CB-463D-A32C-9A2ACDA1F91BQ51857382-B00AAF2F-61C6-4579-BCEC-4990749EDC17
P2860
Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Species differences in the pha ...... ed helper-dependent adenovirus
@ast
Species differences in the pha ...... ed helper-dependent adenovirus
@en
Species differences in the pha ...... ed helper-dependent adenovirus
@nl
type
label
Species differences in the pha ...... ed helper-dependent adenovirus
@ast
Species differences in the pha ...... ed helper-dependent adenovirus
@en
Species differences in the pha ...... ed helper-dependent adenovirus
@nl
prefLabel
Species differences in the pha ...... ed helper-dependent adenovirus
@ast
Species differences in the pha ...... ed helper-dependent adenovirus
@en
Species differences in the pha ...... ed helper-dependent adenovirus
@nl
P2093
P2860
P356
P1476
Species differences in the pha ...... ed helper-dependent adenovirus
@en
P2093
Courtney C Clemens
Kathy Brasky
Maria A Croyle
Piyanuch Wonganan
P2860
P356
10.1021/MP100216H
P407
P577
2010-09-23T00:00:00Z